Doing harm reduction better: syringe exchange in the United States.
about
Bundling occupational safety with harm reduction information as a feasible method for improving police receptiveness to syringe access programs: evidence from three U.S. citiesThe roles of law, client race and program visibility in shaping police interference with the operation of US syringe exchange programsEpidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventionsElectronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes?Correlates of public support toward federal funding for harm reduction strategies.Prevalence, characteristics, and predictors of police training initiatives by US SEPs: building an evidence base for structural interventions.Development and evaluation of a community-based buprenorphine treatment intervention.Psychiatric distress, risk behavior, and treatment enrollment among syringe exchange participantsAccess to healthcare insurance and healthcare services among syringe exchange program clients in Massachusetts: qualitative findings from health navigators with the iDU ("I do") Care Collaborative.Harm reduction services as a point-of-entry to and source of end-of-life care and support for homeless and marginally housed persons who use alcohol and/or illicit drugs: a qualitative analysis.Adverse event associated with a change in nonprescription syringe sale policy.Benefits of concurrent syringe exchange and substance abuse treatment participation.Viral hepatitis among drug users in methadone maintenance: associated factors, vaccination outcomes, and interventionsSuburban Poverty: Barriers to Services and Injury Prevention among Marginalized Women who Use Methamphetamine.Improving treatment enrollment and re-enrollment rates of syringe exchangers: 12-month outcomes.Harmonizing disease prevention and police practice in the implementation of HIV prevention programs: Up-stream strategies from Wilmington, DelawareSyringe acquisition experiences and attitudes among injection drug users undergoing short-term opioid detoxification in Massachusetts and Rhode Island.Hepatitis C viremia and genotype distribution among a sample of nonmedical prescription drug users exposed to HCV in rural Appalachia.Syringe access, syringe sharing, and police encounters among people who inject drugs in New York City: a community-level perspective.The case of a needle exchange policy debate in Fresno, CaliforniaA reexamination of connectivity trends via exponential random graph modeling in two IDU risk networksEvidence-based policy versus morality policy: the case of syringe access programs.Geographic Disparities in Access to Syringe Services Programs Among Young Persons With Hepatitis C Virus Infection in the United States.Decreased Odds of Injection Risk Behavior Associated With Direct Versus Indirect Use of Syringe Exchange: Evidence From Two California Cities.Use of Hepatitis C Virus (HCV) Immunoglobulin G Antibody Avidity as a Biomarker to Estimate the Population-Level Incidence of HCV InfectionHarm reduction in the USA: the research perspective and an archive to David Purchase.Risk: a multidisciplinary concept analysis.Healthcare utilisation and disclosure of injecting drug use among clients of Australia's needle and syringe programs.An observation of lower rates of drug use over time in community syringe exchangers.An Innovative Model for Naloxone Use Within an OTP Setting: A Prospective Cohort Study.Addressing the HIV/AIDS epidemic among Puerto Rican people who inject drugs: the need for a multiregion approach.Needle Syringe Program-Based Primary HealthCare CentersLife after the ban: an assessment of US syringe exchange programs' attitudes about and early experiences with federal fundingStrategies for the elimination of hepatitis C virus infection as a public health threat in the United States
P2860
Q21245628-185CFDA0-AB2D-46EB-9349-5C85B1750BD9Q24599239-394EF169-2EA8-443F-8D64-9925A2208B55Q24634237-E4848F2A-67FA-4E08-B4D3-E5D9E2C68918Q28300623-D9C7A932-7E73-4C06-AAA9-086C0A73FE6DQ30279094-23A6A927-E98C-4E9C-91CF-53DEF8F72160Q30404240-04BB2C9F-8B4A-4619-9952-5CBB377A5966Q33667902-B1AA78C4-0554-4B2D-ABEF-5F8689141C79Q33695524-E63CDDFF-0380-4E15-8FE0-2640F0B6944EQ33706376-21417CB6-3684-4F30-B270-A3FF42EBE808Q34251466-ACC39DAE-25D3-47BD-8DAE-13860A599634Q34434422-AAE18A1A-9A24-4336-99B4-DE6C06E9D5B7Q34669393-FDD30752-26B5-4865-830D-94E67AA7D284Q34765548-AD729891-3F37-48DA-A9D0-53BE2D0A52AFQ35052450-8EB031EF-F089-4CBA-8F77-2B0197270B57Q35925986-4F66B84A-5FD7-469E-973E-09683E3F3839Q36335200-4DD6BA83-E5BE-4D9D-8E9A-D7529702069AQ36502510-F4B82CB0-44D5-48F8-ABF5-178407F06674Q36607811-8D2D3714-C229-4DE2-A85D-95B600EEC5F8Q37347405-2B3A0B5F-439C-4E37-BADB-1F3D6B76665EQ37536378-D13150C3-BDA8-4A28-A85C-62AA0E490146Q37660585-0198D1EE-926A-4392-96A6-29673E042F5DQ38369588-EFDEAB22-9219-48F5-8E49-F47D0788680BQ38840669-A385F3E2-EAB3-4117-B985-0A46B44F2193Q40180896-DF9AD6D6-139B-4789-9DFF-1C8AB3522289Q40832940-7623E17C-5A39-46E8-B519-7432E28235AFQ42338244-C270F940-A67A-47DB-BCB8-7347F123EB66Q44033699-21045A24-2E42-4402-810A-30BBBA97D629Q46027765-17BEB42F-C437-4271-9D55-68C73FE8E774Q46884159-D339E0BC-13D7-49E8-B47A-FB064A9C4F02Q47580649-170B95F9-36D9-4EF9-8485-C690C7FF6BACQ52305479-F2BD69B1-92BD-4DE8-A606-F01CD88F1E01Q55924275-835C36FB-2B11-4F38-9740-ADE5C2E59E31Q56225835-02728D80-207A-4159-8F1A-156630952DF7Q57193075-4E99705C-B3A2-4655-BEE2-0EA4B4153FA9
P2860
Doing harm reduction better: syringe exchange in the United States.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Doing harm reduction better: syringe exchange in the United States.
@ast
Doing harm reduction better: syringe exchange in the United States.
@en
Doing harm reduction better: syringe exchange in the United States.
@nl
type
label
Doing harm reduction better: syringe exchange in the United States.
@ast
Doing harm reduction better: syringe exchange in the United States.
@en
Doing harm reduction better: syringe exchange in the United States.
@nl
prefLabel
Doing harm reduction better: syringe exchange in the United States.
@ast
Doing harm reduction better: syringe exchange in the United States.
@en
Doing harm reduction better: syringe exchange in the United States.
@nl
P2093
P1433
P1476
Doing harm reduction better: syringe exchange in the United States.
@en
P2093
Cullen Goldblatt
David Purchase
Don C Des Jarlais
P304
P356
10.1111/J.1360-0443.2008.02465.X
P407
P577
2009-02-10T00:00:00Z